• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“突破性”革兰氏阴性杆菌菌血症中的同时抗生素水平

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.

作者信息

Anderson E T, Young L S, Hewitt W L

出版信息

Am J Med. 1976 Oct;61(4):493-7. doi: 10.1016/0002-9343(76)90328-4.

DOI:10.1016/0002-9343(76)90328-4
PMID:788512
Abstract

Of 237 cases of gram-negative rod bacteremia observed at the UCLA Medical Center during a 12 month period, 52 (22 per cent) occurred while the patient was receiving antibiotics which inhibited the infecting organism by disc diffusion tests. One half of the plasma samples available from 42 such patients with "breakthrough" bacteremia had subinhibitory circulating antibiotic levels when cultures were positive. Sepsis documented within 72 hours of initiation of therapy was usually due to antibiotic-sensitive Esch. coli and was associated with inadequate antibiotic levels; the patient was usually treated with a penicillin or cephalosporin. The source of bacteremia was most frequently the urinary tract or the biliary tree. In contrast, sepsis occurring more than 72 hours after the administration of antibiotics was frequently caused by multiple antibiotic-resistant Esch. coli in patients treated with gentamicin in adequate dosage and was associated with leukopenia or undrained purulent collections. Therapy ultimately failed in 20 cases (48 per cent): in early "breakthrough" bacteremia, failure was associated with subinhibitory antibiotic levels, and in late "breakthrough" bacteremias with inadequate drainage or impaired host defenses.

摘要

在加州大学洛杉矶分校医疗中心12个月期间观察到的237例革兰氏阴性杆菌菌血症病例中,有52例(22%)发生在患者接受通过纸片扩散试验能抑制感染菌的抗生素治疗时。在42例发生“突破性”菌血症的此类患者中,一半可获得的血浆样本在培养阳性时循环抗生素水平低于抑菌浓度。在开始治疗72小时内记录到的脓毒症通常由对抗生素敏感的大肠杆菌引起,且与抗生素水平不足有关;患者通常接受青霉素或头孢菌素治疗。菌血症的来源最常见的是尿路或胆道。相比之下,在使用足够剂量庆大霉素治疗的患者中,抗生素给药72小时后发生的脓毒症常由多重耐药的大肠杆菌引起,且与白细胞减少或未引流的脓性积液有关。最终20例(48%)治疗失败:在早期“突破性”菌血症中,失败与低于抑菌浓度的抗生素水平有关,而在晚期“突破性”菌血症中,失败与引流不足或宿主防御受损有关。

相似文献

1
Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.“突破性”革兰氏阴性杆菌菌血症中的同时抗生素水平
Am J Med. 1976 Oct;61(4):493-7. doi: 10.1016/0002-9343(76)90328-4.
2
Glucocorticoid and antibiotic effects on hepatic microcirculation and associated host responses in lethal gram-negative bacteremia.糖皮质激素和抗生素对致死性革兰氏阴性菌血症时肝微循环及相关宿主反应的影响
Lab Invest. 1979 Jan;40(1):55-65.
3
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.黎巴嫩发热性中性粒细胞减少成年癌症患者中引起菌血症的第三代头孢菌素耐药肠杆菌科细菌和多重耐药革兰氏阴性菌、作为主要危险因素的广谱抗生素使用以及与预后不良的相关性
Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015.
4
Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.实验性革兰氏阴性菌败血症抗生素治疗期间内毒素释放的动力学
J Infect Dis. 1984 Sep;150(3):380-8. doi: 10.1093/infdis/150.3.380.
5
Antibiotic therapy for gram-negative bacteremia.革兰氏阴性菌血症的抗生素治疗。
Infect Dis Clin North Am. 1991 Dec;5(4):817-34.
6
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
7
Clinical importance of "breakthrough" bacteremia.“突破性”菌血症的临床重要性。
Am J Med. 1984 Feb;76(2):175-80. doi: 10.1016/0002-9343(84)90770-8.
8
Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.抗生素类别在实验性革兰氏阴性菌败血症治疗期间内毒素释放速率中的作用。
J Infect Dis. 1985 Jun;151(6):1012-8. doi: 10.1093/infdis/151.6.1012.
9
Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.在日间治疗中心对发热幼儿的尿路感染采用每日静脉注射抗生素疗法进行治疗。
Pediatrics. 2004 Oct;114(4):e469-76. doi: 10.1542/peds.2004-0421.
10
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].[铜绿假单胞菌血症:与感染源及抗生素耐药性的关联]
Medicina (Kaunas). 2009;45(1):1-7.

引用本文的文献

1
Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy.替加环素治疗期间突破性血流感染危险因素的临床与微生物学分析
Sci Rep. 2025 Feb 4;15(1):4266. doi: 10.1038/s41598-025-88048-7.
2
Serrating through vascular access catheters: a great masquerader with severe systemic manifestations.血管通路导管的锯齿状切割:一种伴有严重全身表现的伪装高手。
BMJ Case Rep. 2021 Apr 7;14(4):e242013. doi: 10.1136/bcr-2021-242013.
3
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
碳青霉烯类治疗期间革兰阴性菌血症突破发生的临床特征及危险因素
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6673-6678. doi: 10.1128/AAC.00984-16. Print 2016 Nov.
4
Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.抗菌药物在儿童和青少年脑脊液中的药代动力学。
Paediatr Drugs. 2013 Apr;15(2):93-117. doi: 10.1007/s40272-013-0017-5.
5
Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy.在接受达托霉素治疗的患者中,因咽峡炎链球菌对达托霉素耐药而发生的突破性菌血症和感染性休克。
Antimicrob Agents Chemother. 2011 Jul;55(7):3639-40. doi: 10.1128/AAC.00231-11. Epub 2011 Apr 18.
6
Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis.gidB 突变赋予结核分枝杆菌低水平链霉素耐药性。
Antimicrob Agents Chemother. 2011 Jun;55(6):2515-22. doi: 10.1128/AAC.01814-10. Epub 2011 Mar 28.
7
Therapeutic drug monitoring of aminoglycosides in neonates.新生儿氨基糖苷类药物的治疗药物监测
Clin Pharmacokinet. 2009;48(2):71-88. doi: 10.2165/00003088-200948020-00001.
8
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration.妥布霉素在成年囊性纤维化患者中的药代动力学:每日一次给药的意义。
Antimicrob Agents Chemother. 2000 Apr;44(4):809-13. doi: 10.1128/AAC.44.4.809-813.2000.
9
Single or multiple daily doses of aminoglycosides: a meta-analysis.氨基糖苷类药物每日单次或多次给药:一项荟萃分析。
BMJ. 1996 Feb 10;312(7027):338-45. doi: 10.1136/bmj.312.7027.338.
10
Aminoglycoside dosage regimens. Is once a day enough?
Clin Pharmacokinet. 1993 Dec;25(6):427-32. doi: 10.2165/00003088-199325060-00002.